NFKB1 and cancer: These include the HES (Kageyama et al., 2007) and HEY (Weber et al., 2014) families of transcriptional repressor genes, c-Myc (Sato et al., 2016), cyclin-D1 (Ronchini and Capobianco, 2001), p21 (Rangarajan et al., 2001), genes of NF-κB pathway such as RELB and NFKB2 (Vilimas et al., 2007), and other genes which regulate the biological functions altered in cancer.